Allercare

What Allercare does

Allercare is a private US-based allergy services company founded in 2021 and headquartered in Blanchard, Oklahoma. The company delivers in-office allergy care — diagnostic testing and immunotherapy treatments — through healthcare provider offices and medical clinics rather than directly to consumers, with the go-to-market targeting enterprise buyers (providers) who then serve patients with allergies. Its service portfolio spans allergy testing, blood-based allergen identification via microarray technology, and immunotherapy delivered in two modalities: sublingual allergy drops (home-administered) and subcutaneous allergy injections (clinic-administered). Allercare also produces a customized mix kit of allergen extracts tailored to each patient's immunotherapy regimen, closing the loop from identification to long-term desensitization.

Under the hood, the diagnostic foundation is microarray-based testing — described as enabling comprehensive allergen detection through a single blood draw — alongside conventional allergy testing panels. Revenue is generated through professional-services fees from diagnostic testing and from the ongoing multi-month-to-multi-year immunotherapy course per patient. The company positions itself around an "intuitive platform for tracking allergens and managing dietary restrictions," though no mobile app, public API, or SDK exists in the input; the platform language refers to the integrated service-plus-content experience rather than a standalone software product. HIPAA compliance is publicly attested on the website, establishing the regulatory baseline required for handling protected health information in this category.

The go-to-market is sales-led and B2B-to-B2C: Allercare onboards healthcare providers and clinics who administer services to patients within their offices. Patient acquisition support is delivered through content marketing — a main website, blog, learning center, resources hub, FAQ, and case studies — operating at the top of the funnel. Pricing is not publicly disclosed. The firm operates with 1–10 employees, has no disclosed funding rounds, no management team bios, no named enterprise customers, no M&A activity, and no documented partnerships in the available record, indicating either a bootstrapped operation or one in pre-traction stage. Geographic scope is single-country (United States) with no published footprint beyond the Blanchard base.

Name

Allercare

Website

https://myallercare.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Allercare is a private US-based allergy services company founded in 2021 in Blanchard that delivers in-office allergy testing and immunotherapy — blood-based microarray diagnostics, sublingual drops, and subcutaneous injections — to patients through partnered healthcare provider offices.

Ownership category

akta.pro rank

Product category

Allergy & Immunotherapy Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Allergy & Immunology Clinics (HLAKAAAA)

akta.pro secondary industries

Allergy & Immunology Diagnostic Testing Centers (Skin/Challenge/PFT) (HLAKAAAL), Autoimmune, Allergy & Specialized Immunology Diagnostics (HLAHAAAK)

Keywords

• Allergy testing services
• Immunotherapy treatments
• Sublingual allergy drops
• Allergy injections
• Microarray diagnostics

Headquarters

HQ city

Blanchard

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Allergy Testing Services: Revenue from providing allergy testing services to patients in clinical settings, including blood tests and microarray-based testing.
2. Immunotherapy Treatments: Revenue from immunotherapy treatments including allergy drops and allergy injections administered to patients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Allercare provides in-office allergy care services centered on diagnostic testing and long-term immunotherapy. Testing includes microarray-based panels and blood allergy tests to identify patient-specific allergens, followed by immunotherapy delivered as either allergy drops (sublingual) or allergy injections (subcutaneous), supported by custom Mix Kit extract preparations.

Product overview

Allercare is an allergy services company offering in-office allergy services. The company provides a comprehensive suite of allergy care including diagnostic testing services (Allergy Testing and Blood Allergy Test using Microarray Technology), immunotherapy treatments (Allergies Immunotherapy, Allergy Injections, and Allergy Drops), and custom treatment components (Mix Kit). The portfolio spans from initial allergen identification through ongoing therapeutic treatment delivery, with both clinic-based and home-administered treatment options.

Differentiator

Problem solved

Functional benefit

Products and services

• Allergy Testing

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• United Allergy Services: United Allergy Services provides allergy testing and immunotherapy services delivered in primary care and specialty physician offices. Its in-office delivery model and immunotherapy offerings closely mirror Allercare's GTM motion and service mix.
• Allergy Partners: Allergy Partners is the largest US network of allergy, asthma, and immunology practices. It directly competes with Allercare by offering in-office allergy testing, immunotherapy (injections and drops), and related clinical services through a multi-site provider network.
• Family Allergy & Asthma: Family Allergy & Asthma operates a multi-state allergy and immunology practice network offering testing, immunotherapy, and asthma management. It is a directly comparable clinical services peer with similar patient-facing offerings to Allercare.

Broad incumbents

• Laboratory Corporation of America (Labcorp): Labcorp is a large clinical laboratory network offering allergy-specific IgE panels and broader immunology testing. It overlaps with Allercare's diagnostic services but operates as a diversified incumbent across all major lab testing categories.
• ALK-Abelló: ALK-Abelló is a global leader in allergy immunotherapy, manufacturing both subcutaneous and sublingual immunotherapy products used by clinicians worldwide. It is comparable to Allercare as a supplier/provider of immunotherapy modalities, but operates at much larger scale across the full allergy value chain.
• Quest Diagnostics: Quest Diagnostics is a major reference laboratory offering blood-based allergy and immunology testing panels to clinicians nationwide. It is comparable to Allercare's blood allergy test and microarray-based diagnostics, but operates as a broad incumbent across all diagnostic categories.
• Stallergenes Greer: Stallergenes Greer is a global allergy immunotherapy company offering sublingual and subcutaneous products as well as diagnostic services. It overlaps with Allercare's immunotherapy and diagnostic offerings but operates as a large incumbent manufacturer rather than a clinical services provider.

Emerging players

• DBV Technologies: DBV Technologies is a clinical-stage biopharmaceutical company developing epicutaneous immunotherapy for food allergies (e.g., Viaskin Peanut). It is comparable to Allercare through its focus on allergy immunotherapy innovation, though it focuses on food allergy indications and operates as a drug developer rather than a clinical services provider.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Allercare